• Skip to main content
  • Skip to navigation
Accessibility
  • Increase font size
  • Decrease font size
  • Sharpen color
  • Grayscale
  • Invert color
  • Default
Disclaimerclose
Menu
Weizmann Institute of Science Department of Molecular Cell Biology
Ravid Straussman Lab
Tumor microenvironment, tumor microbiome and resistance to anti-cancer therapy
Ravid Straussman Lab
  • Home
  • Research
  • Collaborators
  • Group
  • Publications
  • Gallery
  • Join Us
  • Contact Us
  • Home
  • Research
  • Collaborators
  • Group
  • Publications
  • Gallery
  • Join Us
  • Contact Us
You are here
  1. Home ›
  2. Publications

Publications

Press here for relevant publications

Selected papers

Pan-cancer analyses reveal cancer type-specific fungal ecologies and bacteriome Interactions

Pan-cancer analyses reveal cancer type-specific fungal ecologies and bacteriome Interactions
[Cell, 2022]

Ex vivo organotypic cultures for synergistic therapy prioritization

Ex vivo organotypic cultures for synergistic therapy prioritization
[Nature Cancer, 2022]

IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy

IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
[Nature cancer, 2021]

Identification of bacteria-derived HLA-bound peptides in melanoma

Identification of bacteria-derived HLA-bound peptides in melanoma
[Nature, 2021]

The human tumor microbiome is composed of tumor type–specific intracellular bacteria

The human tumor microbiome is composed of tumor type–specific intracellular bacteria
[Science, 2020]

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
[Science, 2017]

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
[Nature, 2012]